![](/img/cover-not-exists.png)
3617 POSTER Cost-Effectiveness of Cetuximab and Bevacizumab in the First-Line Treatment of Metastatic Colorectal Cancer (mCRC) for Patients With KRas Wild-Type Tumours in the United Kingdom
Samyshkin, Y., Hertel, N., Griebsch, I.Volume:
47
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/S0959-8049(11)71214-X
Date:
September, 2011
File:
PDF, 39 KB
english, 2011